Stephen M. Bloch, serving as a director at Liquidia Corp (NASDAQ:LQDA), has completed the sale of 84,800 shares of the company's common equity. According to a Form 4 filing submitted to the Securities and Exchange Commission, the total value of these transactions reached approximately $5.51 million. The divestment was executed over a two-day period, specifically on June 4 and June 5, 2026. The shares were liquidated at weighted average prices that fluctuated between $64.1394 and $66.0786 per share.
The timing of this sale warrants attention, particularly given the stock's recent performance. At the time of the transactions, Liquidia's shares were trading just 1% below their 52-week high of $66.24. This market position follows a substantial 241% return over the preceding year. Despite this significant price appreciation, analysis from InvestingPro suggests that the stock may still be considered undervalued relative to its fundamentals. For investors seeking a deeper understanding of LQDA's valuation metrics and additional strategic insights, a comprehensive Pro Research Report is available through InvestingPro.
Breaking down the transaction details, the sales on June 4 were distributed across three price points: 46,108 shares were sold at a weighted average of $64.4691, 35,208 shares at $65.5824, and 1,420 shares at $66.0786. The following day, June 5, saw an additional 2,064 shares sold at a weighted average price of $64.1394. It is important to note that these shares were held indirectly by Canaan VIII L.P. Mr. Bloch has formally disclaimed beneficial ownership of these securities, except insofar as his pecuniary interest is concerned. He further clarified that he did not participate in the investment decision-making process regarding these specific sales.
Following the completion of these transactions, the Canaan Entities continue to indirectly hold 1,785,242 shares of Liquidia Corp common stock. In addition to his indirect holdings, Mr. Bloch directly holds 65,712 shares of the company's common stock. This retention of direct ownership may signal ongoing alignment with the company's long-term trajectory despite the recent divestment.
Broader market developments are also influencing the current landscape for Liquidia Corp. The company is scheduled to be added to the S&P SmallCap 600 Index effective June 22. This inclusion is predicated on specific criteria, including market capitalization, liquidity, the number of shares available for public trading, and demonstrated profitability. Such index inclusion often brings increased visibility and potential inflows from passive investment funds.
Concurrently, several analyst firms have updated their ratings and price targets for Liquidia, reflecting a growing optimism regarding the company's legal outlook. H.C. Wainwright has raised its price target to $75 while maintaining a Buy rating. The firm cites positive implications stemming from a recent Supreme Court ruling involving Hikma Pharmaceuticals and Amarin. Similarly, Raymond James has reiterated a Strong Buy rating with a $68 price target, also pointing to the favorable implications of the same Supreme Court decision. BTIG has maintained its Buy rating with a $59 price target, attributing the strength in Liquidia's shares to the same legal development. These coordinated upgrades suggest a consensus among analysts that the legal environment is becoming increasingly favorable for the company.
Market data indicates that Liquidia's stock has risen by 3.35%, while the broader S&P 600 Small Cap index has declined by 1.79%. This divergence highlights the specific momentum driving LQDA, potentially linked to the aforementioned legal and index-related catalysts. The interplay between corporate governance actions, such as director sales, and external market catalysts creates a complex environment for investors assessing the true value and future direction of the stock.